The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.46
Bid: 0.45
Ask: 0.47
Change: 0.00 (0.00%)
Spread: 0.02 (4.444%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.46
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Haydale (HAYD): Exuberance, reality; enlightenment now to follow

26 Sep 2018 17:21

Hardman & Co Research Hardman & Co Research: Haydale (HAYD): Exuberance, reality; enlightenment now to follow 26-Sep-2018 / 17:20 GMT/BST


Hardman & Co: Exuberance, reality; enlightenment now to follow

Haydale is competitively well-positioned within the nanomaterial industry, with a unique patented functionalisation process - currently focused on, but not limited to, graphene. Commercial developments for graphene and silicon carbide are progressing well and, while timings of commensurate news releases may be lagging, the long-term risk/reward balance remains favourable. The shares are attractively valued compared with their peer group, on P/NAV and EV/sales, and also on a DCF basis.

Please click here for the full report:

http://hardmanandco.com/docs/default-source/company-docs/haydale-graphene-industries-documents/26.09.18-exuberance-reality-enlightenment-now-to-follow.pdf

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.comFollow us on Twitter @HardmanandCo Contacts: Paul Singer +44 20 7194 7622 ps@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the world with high-quality research, investor engagement programmes and advisory services.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

727763 26-Sep-2018 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
13th Jun 20189:00 amRNSPrice Monitoring Extension
13th Jun 20187:00 amRNSTrading Statement and Director Resignation
25th May 20187:00 amRNSHaydale Ceramics Technologies
16th Apr 20189:10 amRNSNotification of Major Holdings
1st Mar 20187:00 amRNSInterim Results
19th Feb 20187:00 amRNSSupply Agreement with Graphene Platform Corp
25th Jan 20187:00 amRNSTrading Update
18th Jan 20187:00 amRNSChange of Adviser
17th Jan 20187:00 amRNSCommercial Agreement with Talga Resources
18th Dec 20177:00 amRNSShare options and awards, LTIP and PDMR dealings
12th Dec 201711:25 amRNSResult of AGM
20th Nov 20177:00 amRNSNew Patent Application
20th Nov 20177:00 amRNSAnnual Report & Notice of AGM
1st Nov 20177:00 amRNSPDMR Dealings
31st Oct 20175:48 pmRNSNotification of Major Holdings
30th Oct 20177:00 amRNSGrant of US Patent
27th Oct 201710:45 amRNSResult of General Meeting, Issue of Equity and TVR
26th Oct 201710:06 amRNSResult of Conditional Offer
19th Oct 20171:20 pmRNSCREST Clarification
10th Oct 20174:21 pmRNSClose of Accelerated Bookbuild
10th Oct 20177:00 amRNSProposed Accelerated Bookbuild to raise £6 million
10th Oct 20177:00 amRNSFull Year Results
26th Sep 20177:00 amRNSEverpower places initial orders for Chinese market
11th Sep 20177:00 amRNSChange of Adviser
1st Sep 20177:00 amRNSNew Sales Contract
22nd Aug 20177:00 amRNSAdvanced Composites Proposed Collaboration
9th Aug 20177:00 amRNSLaunch of Taiwan operations
19th Jul 20177:00 amRNSTrading update
13th Jul 20177:00 amRNSAppointment of Chairman
29th Jun 20177:00 amRNSGrant of Options
20th Jun 20177:00 amRNSIssue of Equity and Total Voting Rights
24th May 201711:30 amRNSPDMR Dealing
15th May 20177:00 amRNSAcquisition of HTI Minority Interest
11th May 20177:00 amRNSMemorandum of Understanding with Nanospan India
9th May 20177:00 amRNSIssue of Equity and Total Voting Rights
28th Apr 20177:00 amRNSIssue of Shares
25th Apr 20177:00 amRNSPDMR Dealing
19th Apr 20177:00 amRNSPDMR Dealing
10th Apr 20177:00 amRNSIssue of Equity and Total Voting Rights
10th Apr 20177:00 amRNSIssue of Shares
31st Mar 20174:00 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20177:00 amRNSIssue of Shares
27th Mar 20175:05 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Mar 20177:00 amRNSInterim Results
15th Mar 20177:00 amRNSFour-year supply agreement
7th Mar 20177:00 amRNSIssue of Shares
20th Feb 20177:00 amRNSIssue of Shares
3rd Feb 20177:01 amRNSProposed Strategic Investment
3rd Feb 20177:00 amRNSTrading update & Notice of results
16th Jan 201711:45 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.